Brain Biomarkers Market Overview, Growth, Opportunities and Development 2031

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031

Coverage: Brain Biomarkers Market covers analysis By Product (Biomarker Analyzers, Biomarker Test Kits) ; Indication (Alzheimer's disease and other dementias, Huntington's disease, MND And ALS, Parkinson's disease, Stroke) ; End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, Research Laboratories) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Report Date : Mar 2026
Report Code : TIPRE00008668

Category : Life Sciences
Status : Upcoming

Available Report Formats :
No. of Pages : 150

Also Available in :

Korean German Japanese French Chinese Italian Spanish

Buy Now

Page Updated: Mar 2023

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

MARKET OVERVIEW

Brain biomarkers are measurable biological and physiological indicators of brain function and activity. These markers can evaluate the presence, severity, or progression of various brain-related conditions such as neurological disorders, psychiatric disorders, or even traumatic brain injury. The use of brain biomarkers provides several advantages over traditional methods of diagnosis and treatment monitoring. These include increased accuracy, objective measurement, and improved ability to predict treatment response. The end-user industries for brain biomarkers include the pharmaceutical and biotech industries, medical research institutions, and healthcare providers.

MARKET DYNAMICS

The brain biomarkers market is projected to grow in the forecast period owing to increase in geriatric population and neurologic diseases associated with them. Also, investment in R&D and improved understanding of the nature of neurologic diseases is propelling the market growth. The brain biomarkers market is a rapidly growing field with vast potential for the future of medical diagnosis and treatment. The major opportunities in this market include the growing demand for personalized medicine, advancements in technology, and increased funding and investment. These factors drive growth and innovation in the brain biomarkers market, enabling more precise and accurate diagnoses. In the future, the market is expected to expand to include a wider range of applications, including developing new biomarkers for neurological disorders and improving existing ones.

MARKET SCOPE

The "Global Brain Biomarkers Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of market with detailed market segmentation by type, application, and geography. The global brain biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Brain biomarkers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global brain biomarkers market is segmented on the basis of product, Indication, and end user. Based on product, the market is segmented into biomarker analyzers and biomarker test kits. Based on indication, the brain biomarkers market is segmented into alzheimer's disease and other dementias, huntington's disease, MND and ALS, parkinson's disease, and stroke. Based on end user, the market is segmented into ambulatory surgical centers, diagnostic laboratories, hospitals, and research laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global brain biomarkers market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America (SCAM). The Brain biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting brain biomarkers market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America after evaluating political, economic, social, and technological factors effecting the brain biomarkers market in these regions.

MARKET PLAYERS

The report covers key developments in the brain biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from brain biomarkers market are anticipated to lucrative growth opportunities in the future with the rising demand for brain biomarkers market in the global market. Below mentioned is the list of few companies engaged in the brain biomarkers market.

The report also includes the profiles of key brain biomarkers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Advanced Brain Monitoring
Electrical Geodesics, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Siemens Healthineers
BrainScope
Quest Diagnostics
QIAGEN N.V
Natus Medical
Myriad Genetics

Brain Biomarkers Report Scope

Report Attribute	Details
Market size in 2024	US$ XX million
Market Size by 2031	US$ XX Million
Global CAGR (2025 - 2031)	7.0%
Historical Data	2021-2023
Forecast period	2025-2031
Segments Covered	By Product Biomarker Analyzers Biomarker Test Kits By Indication Alzheimer's disease and other dementias Huntington's disease MND And ALS Parkinson's disease Stroke By End User Ambulatory Surgical Centers Diagnostic Laboratories Hospitals Research Laboratories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Advanced Brain Monitoring Electrical Geodesics, Inc. F. Hoffmann-La Roche Ltd Johnson & Johnson Siemens Healthineers BrainScope Quest Diagnostics QIAGEN N.V Natus Medical

Frequently Asked Questions

Which end user segment dominates the knee repair market?

On the basis of end-user market is further broken down into ambulatory surgical centers, diagnostic laboratories, hospitals, research laboratories. The ambulatory surgical centers segment is expected to hold the largest brain biomarkers market share in 2023.

Which product segment dominates the brain biomarkers market?

Based on product, the market is segmented as biomarker analyzers, biomarker test kits. The biomarker analyzers segment is expected to hold the largest brain biomarkers market share in 2023.

What is the expected CAGR of the Brain Biomarkers Market?

The Brain Biomarkers Market is estimated to witness a CAGR of 7.0% from 2023 to 2031

What are the driving factors impacting the brain biomarkers market?

The major factors driving the brain biomarkers market are:

1. Growing Incidence of Neurological Disorders
2. Technological Progress Inhibiting Biomarker Research
3. Growing Need for Psychotropic Medication

What are the market players operating in the brain biomarkers market?

Aesculap implant systems, LLC, DePuy Synthes (Johnson & Johnson), Zimmer Biomet,Smith & Nephew plc, Stryker, Vericel Corporation, Histogenics, Medipost, Conformis, and Bioventus are some of the key players influencing the brain biomarkers market.

Which region is expected to hold the largest share in the global brain biomarkers market?

North America is expected to hold the largest share in the global brain biomarkers market.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Brain Biomarkers Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Related Reports

Biotechnology Instruments Market Cryostat Microbiome Equipment Market Biotechnology Market Citrus Bioflavonoids Market Breast Biopsy System Market Commercializing Biomarkers In Therapeutic And Diagnostic Applications Market Circulating Biomarkers Market Biothrax Market Direct to Consumer Microbiome Analyzing Market Biotinidase Deficiency Market Contactless Biometrics Market Bubble Column Bioreactor Market Biotextiles Market Central Nervous System Biomarkers Market Blue Biotechnology Market Commercial Biotechnology Separation Systems Market Cardiac Bio Implant Devices Market Biotechnology Media, Sera and Reagents Market Dental Biomaterials Market Core Biopsy Needle Market

Testimonials

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

RAN KEDEM Partner, Reali Technologies LTDs

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

JEAN-HERVE JENN Chairman, Future Analytica

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

Reason to Buy